课题基金 / 基金详情

The role of Glutathione in Glutamatergic system dysregulation in Treatment-Resistant Schizophrenia

The role of Glutathione in Glutamatergic system dysregulation in Treatment-Resistant Schizophrenia
谷胱甘肽在难治性精神分裂症谷氨酸能系统失调中的作用
批准号：
320527
负责人：
Graff-Guerrero Ariel
金额：
$57.38万
依托单位：
Centre for Addiction and Mental Health (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-03-01 至 2020-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=320527&lang=en
关键词：
Glutamate Glutathione Magnetic Resonance Spectroscopy Schizophrenia

项目摘要

项目成果

Graff-Guerrero Ariel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Schizophrenia is a chronic, progressive mental illness that affects up to 1% of the population and is the 5th leading causes of disability in industrialized countries. Unfortunately, the current treatment for schizophrenia with antipsychotics are not work
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Long COVID-19 on the human brain
The Muscarinic Hypothesis of Schizophrenia: A [18F]-FP-TZTP PET Study
The role of Glutathione in Glutamatergic system dysregulation in Treatment-Resistant Schizophrenia
Imaging the Limbic Dopamine D3 receptor in Schizophrenia
海外基金